official notice
decision of a deputy commissioner of patents
Patent Application : 658136 in the name of Emory University
Title: Method and compositions for the synthesis of BCH-189 and related compounds
Action: Opposition by Biochem Pharma Inc, a notice under s.210(c) requiring Biochem Pharma Inc produce 17 documents, and in the matter of lawful excuse.
Decision: Issued .
Abstract
The Commissioner issued a notice requiring Biochem Pharma Inc to produce 17 documents. Biochem Pharma Inc claimed lawful excuse for not producing the documents. Those documents had been identified as a result of discovery proceedings in the USA, and Emory had obtained leave from a US Court to put them before the Commissioner, conditional upon the Commissioner considering the documents in confidence.
1. The opponent acceded to the jurisdiction of the Commissioner to require production of the documents (which were not located in Australia).
2. No-one at the hearing had constructive knowledge of the content of the documents. Hence relevance could only be assessed on an 'adjectival' basis.
3. While evidence of the notional person skilled in the art in Australia is paramount for a number of issues, the credibility of such evidence may properly be assessed by having regard to what happened elsewhere.
4. While Biochem Pharma Inc suggest that the 17 documents would be taken out of context, the mere reference to there having been 400,000 pages of documents discovered was insufficient to show that it would be onerous to provide context.
5. While the production will inevitably delay the proceedings, in the present case such delay was not counter to the public interest.
6. Where the Commissioner invoked Regulation 4.3(2)(b), both the documents produced, and any other copy of those documents filed (such as in evidence) are prescribed documents for the purpose of s.55 of the Patents Act.
§ Upon production of the documents, the Commissioner would invoke regulation 4.3(2)(b). As a result, the documents produced would be maintained confidential before the Commissioner.
§ If Biochem Pharma Inc is correct in asserting that documents produced are not thereby filed, then any copies of the documents filed in evidence would still be prescribed documents for the purpose of s.55 of the Act. In the present case, the copy produced to the Commissioner would be an exempt document under s.45 of the Freedom of Information Act 1982. Accordingly, both the produced copy, and any copies served in evidence, would be maintained confidential before the Commissioner.
7. Biochem Pharma Inc had not established any lawful excuse for not producing the documents, and was given 28 days to produce the documents. Since no-one at the hearing had constructive knowledge of the content of the documents, the Commissioner is prepared to reconsider the question of relevance based on the actual content of the documents.
patents act 1990
decision of a deputy commissioner of patents
Re:658136 in the name of Emory University, opposition by Biochem Pharma Inc, a notice under s.210(c) requiring Biochem Pharma Inc produce 17 documents,…
Keep reading for free
Create a free CaseChat account to read Emory University v Biochem Pharma Inc and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1998] APO 50
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.